BSF EnterpriseBSFAF Market Cap is $2.56 Mil as of Jun. 28, 2026. The stock has 3 warning signs investors should review. Among 1,429 Biotechnology companies, BSF Enterprise ranks worse than 94.96% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). BSF Enterprise's share price for the quarter that ended in Sep. 2025 was $0.035. BSF Enterprise's Shares Outstanding (EOP) for the quarter that ended in Sep. 2025 was 128.37 Mil. Therefore, BSF Enterprise's market cap for the quarter that ended in Sep. 2025 was $4.49 Mil.
BSF Enterprise's quarterly market cap
declined
from Sep. 2024 ($5.17 Mil) to Mar. 2025 ($2.47 Mil) but then
increased
from Mar. 2025 ($2.47 Mil) to Sep. 2025 ($4.49 Mil).
BSF Enterprise's annual market cap
declined
from Sep. 2023 ($20.93 Mil) to Sep. 2024 ($5.17 Mil) and
declined
from Sep. 2024 ($5.17 Mil) to Sep. 2025 ($4.49 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. BSF Enterprise's Enterprise Value for Today is $2.36 Mil.
BSF Enterprise (OTCPK:BSFAF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
BSF Enterprise Market Cap Related Terms
BSF Enterprise Market Cap Historical Data
* Premium members only.
The historical data trend for BSF Enterprise's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, BSF Enterprise's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BSF Enterprise Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BSF Enterprise's Market Cap distribution charts can be found below:
* The bar in red indicates where BSF Enterprise's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
BSF Enterprise's Market Cap for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSF Enterprise (BSFAF) has a Market Cap of $2.56 Mil as of Jun. 28, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on BSF Enterprise and its competitors. According to the industry distribution chart, BSF Enterprise ranks #1357 out of 1429 companies in the Biotechnology industry, placing it in the top 95%.
Is BSF Enterprise's Market Cap too high?
BSF Enterprise's current Market Cap is $2.56 Mil. The Biotechnology industry median Market Cap is 112.70. BSF Enterprise's value of $2.56 Mil is 97.7% below this industry median. Based on the distribution chart, BSF Enterprise ranks #1357 out of 1429 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does BSF Enterprise's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BSF Enterprise ranks #1357 out of 1429 companies for Market Cap. This places BSF Enterprise in the lower half of its industry. The industry median Market Cap is 112.70. BSF Enterprise's value of $2.56 Mil is 97.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 112.70, based on 1,429 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BSF Enterprise's current Market Cap of $2.56 Mil is 97.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on BSF Enterprise and its competitors. For the Biotechnology industry, the median Market Cap is 112.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BSF Enterprise's current Market Cap is $2.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BSF Enterprise stock overvalued right now?
BSF Enterprise (BSFAF) has a current Market Cap of $2.56 Mil. The current Market Cap is $2.56 Mil and 97.7% below the Biotechnology industry median of 112.70. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For BSF Enterprise (BSFAF), the current Market Cap is $2.56 Mil as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BSF Enterprise PLC is a United Kingdom-based biotech company. The Company is focused on developing biotechnological solutions using cell-based tissue engineering to help generate cultured meat, lab-grown leather, as well as human corneas, collagen growth and skin substitutes. The Company operates through its wholly owned subsidiary, 3D Bio-Tissues Limited (3DBT), which is a clinical and cellular agriculture company engaged in producing human corneas that could help restore vision to millions of people.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSFAF has been successfully added to your 